Mesut Demirbilek

Investigative Manager at Citia - New York, NY, US

Mesut Demirbilek's Colleagues at Citia
Tommy Oswalt

HR Analyst, Global HR Chief Administrative Office

Contact Tommy Oswalt

Anthony Tedesco

Senior Vice President, Re-Engineering & Strategic Cost Management

Contact Anthony Tedesco

View All Mesut Demirbilek's Colleagues
Mesut Demirbilek's Contact Details
HQ
212-243-2108
Location
Turkey
Company
Citia
Mesut Demirbilek's Company Details
Citia logo, Citia contact details

Citia

New York, NY, US • 20 - 49 Employees
SaaS

Citi's mission is to serve as a trusted partner to our clients by responsibly providing financial services that enable growth and economic progress. Our core activities are safeguarding assets, lending money, making payments and accessing the capital markets on behalf of our clients. We have 200 years of experience helping our clients meet the world's toughest challenges and embrace its greatest opportunities. We are Citi, the global bank – an institution connecting millions of people across hundreds of countries and cities.For information on Citi's commitment to privacy, visit on.citi/privacy.

Enterprise solutions Branding digital platform HTML5 content distribution Content Marketing social media Media Transmedia Entertainment Publishing Cards Advertising Creative Services Analytics Content Strategy SaaS marketing B2B Martech Management Consulting Services Marketing and Advertising
Details about Citia
Frequently Asked Questions about Mesut Demirbilek
Mesut Demirbilek currently works for Citi.
Mesut Demirbilek's role at Citi is Investigative Manager.
Mesut Demirbilek's email address is ***@citigroup.com. To view Mesut Demirbilek's full email address, please signup to ConnectPlex.
Mesut Demirbilek works in the Financial Services industry.
Mesut Demirbilek's colleagues at Citia are Hans Neumann, Hans Neumann, Tommy Oswalt, Baljit Baljit, Vaibhav Khot, Latoya Hudson, Anthony Tedesco and others.
Mesut Demirbilek's phone number is 212-243-2108
See more information about Mesut Demirbilek